The Advanced Research Projects Agency for Health (ARPA-H) has selected three academic research teams to receive funding from a $100 million initiative aimed at developing therapies to repair and regrow damaged joints. The teams will focus on testing experimental regenerative medicines for treating osteoarthritis through clinical trials.
The funding represents a significant federal investment in regenerative medicine approaches to joint disease, moving beyond traditional pain management to potentially restore joint function. Osteoarthritis affects millions of Americans and currently has limited treatment options that primarily focus on symptom relief rather than tissue repair.